This is the authors' abstract. We don't add key points for this paper.
AIM: Since 2014, enzyme replacement therapy (ERT) has been available for treatment of Morquio A syndrome. During clinical trials, urinary keratan sulfate (KS) has been a useful biomarker and showed a marked decrease in patients on ERT, demonstrating therapy efficacy. Unfortunately, quantitative urinary KS testing is not widely available in biochemical genetics laboratories for efficient monitoring and follow-up of treated patients. MATERIALS & METHODS: A tandem mass spectrometry methodology was devised to analyze KS disaccharides and creatinine in urine specimens collected on filter paper. RESULTS: All Morquio A patients presented abnormal results pretreatment compared with reference values. CONCLUSION: This collection procedure can be performed by patients at home and filter papers sent by regular mail to a specialized laboratory, facilitating follow-up of patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Auray‐Blais et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: